Observational Case Series of Three Individuals with Amyotrophic Lateral Sclerosis Using Biophoton Generators

Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by degeneration of upper and lower motor neurons, leading to progressive weakness, bulbar dysfunction, and respiratory failure. Current therapeutic options provide limited benefit, and management remains largely supportive. Observational case reports may contribute to hypothesis generation in conditions with significant unmet clinical need. Objective: To document and descriptively analyze patient- and caregiver-reported observations temporally associated with proximity use of wellness devices in individuals diagnosed with ALS. Methods: We report a three-case observational series derived from patient and caregiver correspondence. In each case, individuals diagnosed with ALS used Tesla BioHealing® BioHealers intended for general wellness, near the body. Use occurred outside of formal clinical protocols. No standardized neurological scales (e.g., ALSFRS-R), quantitative motor testing, electrophysiological monitoring, or blind assessments were performed. Outcomes were based exclusively on self-report. Results: Across cases, reported domains included perceived improvements in peripheral circulation, hand mobility, swallowing coordination, speech clarity, bowel regularity, sleep quality, and energy levels. One case described a reported four-year period of clinical stability with preserved energy. Sensory changes (e.g., tingling, altered limb perception) were also described. No device-related adverse effects were reported. However, no objective clinical measurements were obtained to confirm functional change or disease stability. Conclusion: This three-case observational series documents patient-reported positive experiences associated with proximity use of wellness devices in individuals diagnosed with ALS. Due to the uncontrolled design, reliance on self-report, and absence of objective outcome measures, no conclusions regarding causality or clinical efficacy can be drawn. These observations are hypothesis-generating and support the rationale for prospective, controlled feasibility studies incorporating standardized neurological metrics and appropriate comparators.